SPRB
Companies
NASDAQ
Spruce Biosciences Inc.
Health Care
$0.07
-$0.35 (-83.33%)
Price Chart
Overview
About SPRB
spruce biosciences is a clinical stage biopharmaceutical company focused on developing novel therapies for rare diseases affecting the endocrine system.
Market Cap
$27.9M
Volume
25.5K
Avg. Volume
17.9K
P/E Ratio
-0.31554347
Dividend Yield
0.00%
Employees
30.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.78
Moderate Correlation
Volatility
High (0.74)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, SPRB shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$27.9M
Volume25.5K
P/E Ratio-0.32
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
August 13, 2024Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025